320 related articles for article (PubMed ID: 32735147)
1. Open access in silico tools to predict the ADMET profiling of drug candidates.
Kar S; Leszczynski J
Expert Opin Drug Discov; 2020 Dec; 15(12):1473-1487. PubMed ID: 32735147
[TBL] [Abstract][Full Text] [Related]
2. ADMET Profiling in Drug Discovery and Development: Perspectives of In Silico, In Vitro and Integrated Approaches.
Daoud NE; Borah P; Deb PK; Venugopala KN; Hourani W; Alzweiri M; Bardaweel SK; Tiwari V
Curr Drug Metab; 2021; 22(7):503-522. PubMed ID: 34225615
[TBL] [Abstract][Full Text] [Related]
3. In silico ADME-Tox modeling: progress and prospects.
Alqahtani S
Expert Opin Drug Metab Toxicol; 2017 Nov; 13(11):1147-1158. PubMed ID: 28988506
[TBL] [Abstract][Full Text] [Related]
4. In Silico Tools and Software to Predict ADMET of New Drug Candidates.
Kar S; Roy K; Leszczynski J
Methods Mol Biol; 2022; 2425():85-115. PubMed ID: 35188629
[TBL] [Abstract][Full Text] [Related]
5. ADMET in silico modelling: towards prediction paradise?
van de Waterbeemd H; Gifford E
Nat Rev Drug Discov; 2003 Mar; 2(3):192-204. PubMed ID: 12612645
[TBL] [Abstract][Full Text] [Related]
6. A Recent Appraisal of Artificial Intelligence and In Silico ADMET Prediction in the Early Stages of Drug Discovery.
Kumar A; Kini SG; Rathi E
Mini Rev Med Chem; 2021; 21(18):2788-2800. PubMed ID: 33797376
[TBL] [Abstract][Full Text] [Related]
7. Modeling ADMET.
Ghosh J; Lawless MS; Waldman M; Gombar V; Fraczkiewicz R
Methods Mol Biol; 2016; 1425():63-83. PubMed ID: 27311462
[TBL] [Abstract][Full Text] [Related]
8. ADMET profiling of geographically diverse phytochemical using chemoinformatic tools.
Fatima S; Gupta P; Sharma S; Sharma A; Agarwal SM
Future Med Chem; 2020 Jan; 12(1):69-87. PubMed ID: 31793338
[No Abstract] [Full Text] [Related]
9. The importance of employing computational resources for the automation of drug discovery.
Rosales-Hernández MC; Correa-Basurto J
Expert Opin Drug Discov; 2015 Mar; 10(3):213-9. PubMed ID: 25682781
[TBL] [Abstract][Full Text] [Related]
10. Combating Diseases with Computational Strategies Used for Drug Design and Discovery.
Makhouri FR; Ghasemi JB
Curr Top Med Chem; 2018; 18(32):2743-2773. PubMed ID: 30663568
[TBL] [Abstract][Full Text] [Related]
11. In silico prediction of ADMET properties: how far have we come?
Dearden JC
Expert Opin Drug Metab Toxicol; 2007 Oct; 3(5):635-9. PubMed ID: 17916052
[TBL] [Abstract][Full Text] [Related]
12. Predictive QSAR modeling for the successful predictions of the ADMET properties of candidate drug molecules.
Khan MT; Sylte I
Curr Drug Discov Technol; 2007 Oct; 4(3):141-9. PubMed ID: 17985997
[TBL] [Abstract][Full Text] [Related]
13. Improving compound quality through in vitro and in silico physicochemical profiling.
van de Waterbeemd H
Chem Biodivers; 2009 Nov; 6(11):1760-6. PubMed ID: 19937820
[TBL] [Abstract][Full Text] [Related]
14. Computational Drug Designing and Prediction Of Important Parameters Using in silico Methods- A Review.
Khan T; Lawrence AJ; Azad I; Raza S; Joshi S; Khan AR
Curr Comput Aided Drug Des; 2019; 15(5):384-397. PubMed ID: 30914032
[TBL] [Abstract][Full Text] [Related]
15. In silico approaches and tools for the prediction of drug metabolism and fate: A review.
Kazmi SR; Jun R; Yu MS; Jung C; Na D
Comput Biol Med; 2019 Mar; 106():54-64. PubMed ID: 30682640
[TBL] [Abstract][Full Text] [Related]
16. Integration of in silico and in vitro tools for scaffold optimization during drug discovery: predicting P-glycoprotein efflux.
Desai PV; Sawada GA; Watson IA; Raub TJ
Mol Pharm; 2013 Apr; 10(4):1249-61. PubMed ID: 23363443
[TBL] [Abstract][Full Text] [Related]
17. Informing the Selection of Screening Hit Series with in Silico Absorption, Distribution, Metabolism, Excretion, and Toxicity Profiles.
Sanders JM; Beshore DC; Culberson JC; Fells JI; Imbriglio JE; Gunaydin H; Haidle AM; Labroli M; Mattioni BE; Sciammetta N; Shipe WD; Sheridan RP; Suen LM; Verras A; Walji A; Joshi EM; Bueters T
J Med Chem; 2017 Aug; 60(16):6771-6780. PubMed ID: 28418656
[TBL] [Abstract][Full Text] [Related]
18. The role of absorption, distribution, metabolism, excretion and toxicity in drug discovery.
Lin J; Sahakian DC; de Morais SM; Xu JJ; Polzer RJ; Winter SM
Curr Top Med Chem; 2003; 3(10):1125-54. PubMed ID: 12769713
[TBL] [Abstract][Full Text] [Related]
19. Toward in silico structure-based ADMET prediction in drug discovery.
Moroy G; Martiny VY; Vayer P; Villoutreix BO; Miteva MA
Drug Discov Today; 2012 Jan; 17(1-2):44-55. PubMed ID: 22056716
[TBL] [Abstract][Full Text] [Related]
20. Machine Learning for In Silico ADMET Prediction.
Jia L; Gao H
Methods Mol Biol; 2022; 2390():447-460. PubMed ID: 34731482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
